Skip to ContentSkip to Navigation
About us Faculty of Science and Engineering Our Research GRIP PTEE

Theses

Date

Thesis

2024-03-18

Indrė Trečiokienė

Managing High Blood Pressure: Investigating the role of healthcare professionals and drug utilization

Prof. Katja Taxis

Prof. Maarten Postma

2024-01-16

Hao Tran

Adverse drug reactions in the view of clinical pharmacology: a focus on the female population

Prof. Eelko Hak

Dr Henk Groen
2024-01-09

Adrienne Chan

International diversity in psychotropic medication use: a pharmacoepidemiological perspective

Prof. Katja Taxis

2023-11-14

Marloes Dankers

New medicines in primary care: perspectives and practices of healthcare professionals

Prof. dr ir. Liset van Dijk
2023-11-08

Sajad Emamipour

Economic evaluations of precision medicine: case studies in diabetes

Prof. Talitha Feenstra

Prof. Maarten Postma

2023-07-04

Laura Schackmann

Pharmacy staff-patient interactions in challenging situations: understanding the roots and ways to flourish patient-centered communication

Prof. dr ir. Liset van Dijk

2023-02-20

Monika Oktora

Treatment patterns and deprescribing in people with type 2 diabetes

Prof. Eelko Hak

2023-02-14

Naomi Jessurun

The metabolization of drugs as a factor in the development of adverse drug reactions

Prof. Eugène van Puijenbroek

2023-01-30

Corine Rollema

Perspectives on intranasal administration of corticosteroids: insights into different aspects related to patients, administration techniques and instructions

Prof. Eric

van Roon

2022-11-29

Fajri Gafar

Optimization of tuberculosis treatment in children and adolescents. Epidemiological and pharmacological approaches

Prof. Katja Taxis

2022-10-31

Johanne Rozema

Real-world studies of patients with myelodysplastic syndromes. Survival, treatment and outcomes in a population-based setting

Prof. Eric
van Roon
2022-09-19

Tanja Fens-Lazova

Perspectives on medication safety and use. Pharmacoeconomics, public policy & practice and pharmacists education

Prof. Maarten Postma

Prof. Eugène van Puijenbroek

2022-03-15

Joep Scholl

Signal detection in Pharmcovigilance. Time for a new era?

Prof. Eugène van Puijenbroek

Prof. Eelko Hak

2021-10-15

Nanno Schreuder

Exploring drug safety of radiopharmaceuticals

Prof. Eugène van Puijenbroek

Prof. Jos Kosterink

2021-10-11

Berdien Oortgiesen

Real-worl studies of patients with mutiple myeloma. Future perspectives on symptom assessment and therapy

Prof. Eric van Roon

2020-11-27

Karin Larmené-Beld

Ready to administer parental medication produced by hospital pharmacy

Prof. K. Taxis

Prof. M.J. Postma

Prof. H.W. Frijlink

2020-10-12

Sylvi Irawati

Challenges in the use of preventive cardiovascular medications in Indonesia and The Netherlands

Prof. E. Hak

Prof. K. Taxis

2020-10-06

Sofa Dewi Alfian

Adherence to antihypertensive or antihyperlipidemic co-medications in diabetis

Prof. E. Hak

Prof P. Denig

2020-05-08

Yuanyuan Wang

Effectiveness and safety of medicines used in COPD patients: pharmacoepidemiological studies

Prof. E. Hak

Prof. M. Boezen

2020-02-24

Ivan Pradipta

Improving treatment outcomes of tuberculosis: towards an antimicrobial stewardship program

Prof. E. Hak

Prof. J.W. Alffenaar

2020-02-10

Elfride Sianturi

Exploring strategies to optimize pharmacotherapy with antiretrovirals in Papuans living with HIV

Prof. K. Taxis

Prof. B. Wilffert

2019-03-22

Heleen van der Meer

Describing in older people. Development and evaluation of complex healthcare interventions

Prof. dr K. Taxis
Prof. dr L.G. Pont
2018-12-21

Willem van der Veen

Information technology and medication safety

Prof. dr K. Taxis
Prof. dr P.M.L.A. van den Bemt
Prof. dr J.J. de Gier
2018-11-30

Mirjam Simoons

Somatic monitoring of patients with mood and anxiety disorders: Problem definition, implementation and further explorations

Prof. dr E.N. van Roon

Prof. dr R.A. Schoevers
2018-09-14

Maarten van Wijhe

The public health impact of vaccination programmes in the Netherlands

Prof. dr M.J. Postma

Prof. dr J. Wallinga
2018-06-29

Ury Arifin

Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients

Prof. dr M.J. Postma
2018-06-25

Neily Zakiyah

Women's health from a global economic perspective

Prof. dr M.J. Postma
2018-03-23

Leàn Rolfes

Patient participation in pharmacovigilance

Prof. dr E.P. van Puijenbroek
Prof. dr K. Taxis
2018-03-16

Thang Nuyen

Medication use for acute coronary syndrome in Vietnam

Prof. dr K. Taxis
Prof. dr B. Wilffert
Prof. dr T.T. Pham
2018-01-26

Eva van Doorn

Improving influenza prevention. Why universal influenza vaccines are needed

Prof. dr E. Hak

Prof. dr A.L.W. Huckriede

2017-08-12

Jurjen van der Schans

ADHD and atopic diseases. Pharmacoepidemiological studies

Prof. dr E. Hak

Prof. dr P.J. Hoekstra

Dr T.W. de Vries
2017-06-02

Jan Peter Yska

Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet

Prof. dr E.N. van Roon

Prof. dr B. Wilffert
2017-04-24

Nur Aizati Athirah Daud

Paving ways for personalizing drug therapy during pregnancy

Prof. dr B. Wilffert

Dr J.E.H. Bergman
2017-02-17

Didik Setiawan

HPV vaccination in Indonesia: A health-economic & comparative perspective

Prof. dr M.J. Postma

Prof. dr B. Wilffert
2016-12-09

Nyashadzaishe Mafirakureva

Health economics of blood transfusion in Zimbabwe

Prof. dr M.J. Postma

Dr M. van Hulst

Dr S. Khoza
2016-12-09

Tonderai Mapako

Risk modelling of transfusion transmissible infections

Prof. dr M.J. Postma

Dr M. van Hulst
2016-11-18

Renata Šmit

Health economics of tick-borne diseases

Prof. dr M.J. Postma

Prof. dr K. Poelstra
2016-09-23

Lan Nguyen

Health economics of screening for hypertension in Vietnam

Prof. dr M.J. Postma

Dr C.C.M. Schuiling-Veninga

Dr Nguyen Thi Bach Yen

Dr E.P. Wright
2016-09-12

Jovan Mihajlović

Health economics of targeted cancer therapies: A comparative analysis for Serbia and the Netherlands

Prof. dr M.J. Postma

Dr P. Pechlivanglou
2016-06-21

Maryam Darvishian

Real-world influenza vaccine effectiveness: New designs and methods to adjust for confounding and bias

Prof. dr E. Hak

Prof. dr E.R. van den Heuvel
2016-06-17

Hans-Joerg Fugel

Economics of stratified medicine

Prof. dr M.J. Postma

Dr M. Nuijten

Dr K. Redekop
2016-06-17

Lisette Berm

Optimizing treatment with psychotropic agents through precision drug therapy: It is not about the mean

Prof. dr B. Wilffert

Prof. dr E. Hak
2016-03-11

Maarten Bijlsma

Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology

Prof. dr E. Hak

Prof. dr S. Vansteelandt
2016-03-02

Linda de Jong

Data quality and methodology in studies on maternal medication use in relation to congenital anomalies
Prof. dr I.M. van Langen

Prof. dr L.T.W. de Jong-van den Berg
2016-02-26

Dianna de Vries

Statin treatment in type 2 diabetes patients

Prof. dr E. Hak

Prof. dr P. Denig

Prof. dr M.J. Postma
2016-02-19

Bianca Mulder

Medication use during pregnancy and atopic

Prof. dr E. Hak

Prof. dr S.S. Jick
2016-01-25

Priscilla Zetstra-van der Woude

Data collection on risk factors in pregnancy

Prof. dr L.T.W. de Jong-van den Berg
2015-12-22

Jelena Stevanovic

Pharmacoeconomics of cardiovascular disease prevention

Prof. dr M.J. Postma
2015-12-04

Koen Pouwels

Self-controlled designs to control confounding

Prof. dr E. Hak
2015-11-17

Jan Wijnia

Early detection of mental and motor symptoms in the Wernicke-Korakoff Syndrome

Prof. dr C.I. Mulder

Prof. dr A.J.M. Loonen
2015-09-25

Job van Boven

Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness

Prof. dr M.J. Postma

Prof. dr T. van der Molen
2015-09-16

John Pitman

The influence and impact of the U.S. President's Emergency Plan for AIDS Relief (PERFAR) on blood transfusin services in Africa. Case studies from Namibia

Prof. dr M.J. Postma

Prof. dr T.S. van der Werf
2015-06-26

Marlies Geurts

Integrated Pharmaceutical Care. Cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan

Prof. dr J.J. de Gier

Prof. dr J.R.B.J. Brouwers

Prof. dr P.A. de Graeff
2015-05-29

Nikolas Kotsopoulos

Novel economic perspectives on prevention and treatment: case studies for paediatric, adolescent and adult infectious and chronic diseases

Prof. dr M.J. Postma

Dr M. Connolly
2015-05-29

Bo Standaert

Exploring new ways of measuring the economic value of vaccination with an application to the prevention of rotaviral disease

Prof. dr M.J. Postma

Prof. dr O. Ethgen
2015-05-01

Bart Heeg

Modelling chronic diseases for reimbursement purposes

Prof. dr M.J. Postma

Prof. dr E. Buskens

Prof. dr B.A. van Hout
2014-11-03

Thao Huong Nguyen

Medication Safety in Vietnamese Hospitals. A focus on medication errors and safety culture

Prof. dr K. Taxis

Prof. dr F.M. Haaijer-Ruskamp

Prof. dr J.R.B.J. Brouwers
2014-06-27

Auliya Suwantika

Economic evaluations of non-traditional vaccinations in middle-income countries: Indonesia as a reference case

Prof. dr M.J. Postma

Dr K. Lestari
2014-05-28

Giedre Gefenaite

Newly introduced vaccines. Effectiveness and deterninants of acceptance

Prof. dr E. Hak

Prof. dr R.P. Stolk
2014-04-07

Susana Monteiro

Driving-impairing Medicines and Traffic Safety. Patients' Perspectives

Prof. dr J.J. de Gier

Dr ir. L. van Dijk
2013-10-28

Josien Riphagen-Dalhuisen

Influenza vaccination of health care workers

Prof. dr E. Hak
2013-10-25

Fenneke van Hasselt

Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions

Prof. dr A.J.M. Loonen

Prof. dr M.J. Postma

Dr M.J.T. Oud

Dr P.F.M. Krabbe
2013-09-13

Mehraj Parouty

Inequality Aversion to Posterity: Discounting Human Lives

Prof. dr M.J. Postma
2013-06-28

Hoa Dinh Vu

Clinical Pharmacology of Tuberculosis Drugs and Tuberculosis Control in Developing World. The involvement of Private Pharmacy and the individualization of treatment using Dried blood spot

Prof. dr J.R.B.J. Brouwers

Prof. dr D.R.A. Uges

Prof. dr V.H. Le†/ Prof. dr D.H. Nguyen
2013-06-07

Timothy Broesamle

Designing Health Care Services Using Systems Thinking: A Theory, A Method and their Application in the Dutch Community Pharmacy

Prof. dr J.J. de Gier

Prof. dr J.J. van der Werf
2013-05-31

Josta de Jong

Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands

Prof. dr L.T.W. de Jong-van den Berg

Dr T.W. de Vries
2013-04-17

Tjalke Westra

Health-economic Modelling of Human Papillomavirus Vaccination

Prof. dr M.J. Postma

Prof. dr J.C. Wilschut

Prof. dr C.A.H.H. Daemen

Prof. dr H.W. Nijman
2013-03-22

Irene Lako

Depressive Symptoms in Patients with Schizophrenia. Count symptoms that Count

Prof. dr K. Taxis

Prof. dr D. Wiersma
2013-02-25

Mark Rozenbaum

Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease

Prof. dr M.J. Postma

Prof. dr E. Hak
2013-02-25

Albert Jan van Hoek

The Epidemiology and Cost-effectiveness of Vaccination Strategies against Infectious Diseases: a Focus on Varicella Zoster, Pandemic influenza A/H1N1 2009, Streptococcus Pneumonia

Prof. dr M.J. Postma

Prof. dr W.J. Edmunds

Prof. dr E. Miller
2013-01-11

Peter ter Horst

Clinical Pharmacology of Antidepressants During Pregnancy

Prof. dr B. Wilffert

Prof. dr L.T.W. de Jong-van den Berg
2012-12-18

Petros Pechlivanoglou

Applying and Extending Mixed-effects Models in Health Economics and Outcomes Research

Prof. dr M.J. Postma

Prof. dr J.E. Wieringa
2012-11-16

Ineke Crijns

Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes

Prof. dr L.T.W. de Jong-van den Berg
2012-10-10

Janna Munster

Q Fever During Pregnancy. Lessons From the Dutch Epidemic

Prof. dr E. Hak

Prof. dr J.G. Aarnoudse

2012-06-04

Linda Harmark

Web-based intensive monitoring : a patient based pharmacovigilance tool

Prof. dr A.C. van Grootheest

Prof. dr J.J. de Gier
2012-03-16

Stefan Vegter

The value of personalized approaches to improve pharmacotherapy in renal disease

Prof. dr M.J. Postma

Prof. dr G. Navis
2012-02-24

Silvia Ravera

Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication

Prof. dr J.J. de Gier

Prof. dr. L.T.W de Jong-van den Berg
2012-01-27

Hong Anh Thi Tu

Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam

Prof. dr M.J. Postma
2011-12-09

Janneke Boersma-Jentink

Risk assessment of antiepileptic drugs in pregnancy

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr H. Dolk
2011-11-18

Florence van Hunsel

The contribution of direct patient reporting to pharmacovigilance

Prof. dr A.C. van Grootheest

Prof. dr L.T.W. de Jong-van den Berg
2011-02-04

Evert Jan Mookhoek

Patterns of somatic disease in residential psychiatric patients : surveys of dyspepsia, diabetes and skin disease

Prof. dr A.J.M. Loonen

Prof. dr J.R.B.J. Brouwers
2011-02-04

Anna Krabbe Lugner

Cost-effectiveness of controlling infectious diseases from a public health perspective

Prof. dr M.J. Postma

Dr J. Wallinga
2010-10-08

Michiel Duyvendak

Pharmaceutical care by clinical pharmacists in patients with musculoskeletal disease

Prof. dr J.R.B.J. Brouwers
2010-04-16

Mark Connolly

The Economics of assisted reproduction. Costs and consequences of fertility treatments

Prof. dr M.J. Postma

Prof. dr W. Ledger
2010-01-11

Marian Bakker

The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy

Prof. dr C.H.C.M. Buijs

Prof. dr L.T.W. de Jong-van den Berg
2010-01-08

Susanne Schorr

Drug safety in patients with psychotic disorders

Prof. dr K. Taxis

Prof. dr J.R.B.J. Brouwers
2010-01-08

Robin de Vries

Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making

Prof. dr M.J. Postma

Prof. dr L.T.W. de Jong-van den Berg
2009-11-09

Asmar Al Hadithy

Pharmacogenetics of Antipsychotic-Induced Parkinsonism and Tardive Dyskenesia: a Focus on African-Caribbeans and Slavonic Caucasians

Prof. dr J.R.B.J. Brouwers

Prof. dr A.J.M. Loonen
2009-06-26

Maarten Beinema

The optimization of coumarin anticoagulant therapy: Pharmacogenetics and computer assisted dose finding

Prof. dr J.R.B.J. Brouwers

Prof. dr J. v.d. Meer
2009-06-12

Cornelis Boersma

Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings

Prof. dr M.J. Postma

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr P.E. de Jong
2009-05-11

Gijs Hubben

Cost-effectiveness of infectious disease interventions : combining economic modelling and web technology to support decision making

Prof. dr M.J. Postma
2009-03-20

Fokaline Vroom

Drug use in pregnancy. Exploring the field of DMARDs in pregnancy

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr J.R.B.J. Brouwers

Prof. dr M.A.F.J. van de Laar
2008-11-28

Mark Reinders

Practice research in the field of gout. Clinical pharmacology of antihyperuricemic drugs

Prof. dr J.R.B.J. Brouwers

Prof. dr M.A.F.J. v.d. Laar
2008-11-14

Tjalling de Vries

Improving care in paediatric asthma: patients, prescriptions, pharmacovigilance, pathogens, and particles

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr E.J. Duiverman
2008-10-17

Beitske Smink

Benzodiazepines and traffic safety. Forensic, analytical-toxicological and epidemiological aspects of driving under the influence of benzodiazepines

Prof. dr D.R.A. Uges

Prof. dr A.C.G. Egberts

Prof. dr J.J. de Gier
2006-12-08

Willemijn Meijer

Drug safety in pregnancy. Studying and communicating teratogenic risks

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr J.R.B.J. Brouwers
2006-10-02

Adrianne Faber

Stimulant treatment in children: a Dutch perspective

Prof. dr L.T.W. de Jong-van den Berg
2006-09-15

Jarir Atthobari

Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr P.E. de Jong
2006-06-30

Rogier Klok

Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection

Prof. dr J.R.B.J. Brouwers

Prof. dr M.J. Postma
2005-05-11

Frank Jansman

Chemotherapy for patients with colorectal Cancer

Prof. dr J.R.B.J. Brouwers

Prof. dr D.Th. Sleijfer

2005-03-11

Eric van Roon

Practice research in the field of rheumatoid arthritis

Prof. dr J.R.B.J. Brouwers

Prof. dr M.A.F.J. van de Laar

2004-12-17

Ada Stuurman-Bieze

Interventions on the principle of Pulmonary Medication Profiles

Prof. dr L.T.W. de Jong-van den Berg

Dr Th.F.J. Tromp

2004-11-19

Andrea Tramarin

The changing economic burden of HIV/AIDS in Italy

Prof. dr J.R.B.J. Brouwers

Dr M.J. Postma

2004-01-09

Jasper Bos

Pharmacoeconomics in infectious disease. The evaluation of prevention programmes

Prof. dr L.T.W. de Jong-van den Berg

Dr M.J. Postma

2003-12-01

Vera Deneer

Episodic tretment and prevention of paroxysmal atrial fibrilation: studies on flecainide and sotalol

Prof. dr J.R.B.J. Brouwers

Prof. dr J.H. Kingma

2003-11-18

Kees van Grootheest

Improving Pharmacovigilance and the Role of the Pharmacist

Prof. dr L.T.W. de Jong-van den Berg

Dr E.P. van Puijenbroek

2003-10-03

Eric Schirm

Drug Exposure from conception till adulthood

Prof. dr L.T.W. de Jong-van den Berg

Dr H. Tobi

2003-10-03

Claudia Rijcken

Pharmacy Data as a Tool for assessing Antypsychotic Drug Use

Prof. dr L.T.W. de Jong-van den Berg

2003-01-31

Taco Monster

Assessing drug influences on urinary albumin excretion

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr P.E. de Jong

Dr H. Tobi

2002-06-07

Karen van Dijk

Pharmacotherapy in frail elderly

Prof. dr L.T.W. de Jong-van den Berg

Prof. J.R.B.J. Brouwers

2002-02-22

Patricia van den Bemt

Drug safety in hospitalised patients

Prof. dr J.R.B.J. Brouwers

Prof. dr A.C.G. Egberts

2001-11-10

Nicolien Wieringa

Connecting pre-marketing clinical research and medical practice: the case of the cardiovascular drugs

Prof. dr R. Vos

Prof. dr P.A. de Graeff

2001-06-18

Hermien de Walle

Awareness and use of folic acid in the Netherlands: from science to practice

Prof. dr C.H.C.M. Buys

Prof. dr L.T.W. de Jong-van den Berg

2001-05-04

Roel Fijn

Managing Rational Pharmacotherapy in Hospitals: what about drug formularies and pharmacotherapeutic guidelines?

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr J.R.B.J. Brouwers

2001-01-19

Marc Weeber

Literature-based Discovery in Biomedicine

Prof. dr R. Vos

Prof. dr L.T.W. de Jong-van den Berg

2000-06-21

Jennita Reefhuis

The Use of Birth Defect Registries for Etiological Research

Prof. dr C.H.C.M. Buys

Prof. dr L.T.W. de Jong-van den Berg

2000-01-28

Foppe van Mil

Pharmaceutical care, the future of pharmacy

Prof. dr Th.F.J. Tromp

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr J. McElnay

1998-10-16

Corinne de Vries

Collaboration in healthcare, the tango to drug safety

Prof. dr L.T.W. de Jong-van den Berg

Prof. dr Th.F.J. Tromp

1998-01-30

Floor Rikken

Adverse Drug Reactions in a Different Context; a scientometric approach towards adverse drug reactions as a trigger for the development of new drugs

Prof. dr R. Vos

Prof. dr D.K.F. Meijer

Prof. dr W. van Rossum

1995-09-22

Anke van Trigt

Making News about Medicines

Prof. dr Th.F.J. Tromp

Prof. dr M.N.G. Dukes

Prof. dr F.M. Haaijer-Ruskamp

Dr L.T.W. de Jong-van den Berg

1995-07-07

Miriam Sturkenboom

A Field-oriented Postmarketing Surveillance Study on the Teratogen Acitretin

Prof. dr H. Wesseling

Prof. dr D.K.F. Meijer

Dr L.T.W. de Jong-van den Berg

1992-04-29

Lolkje de Jong-van den Berg

Drug Utilization Studies in Pregnancy; what can they contribute to safety assessment?

Prof. dr M.N.G. Dukes

Prof. dr H. Wesseling

1989-12-11

Rein Vos

Drugs Looking for Diseases; a descriptive model for the process of innovative drug research with special reference to the development of beta blockers and the calcium antagonists

Prof. dr D.K.F. Meijer

Prof. dr A.J. Dunning

Prof. dr T.A.F. Kuipers

Dr H.W.H.J. Bodewitz

Laatst gewijzigd:20 maart 2024 15:21